Ownership history in Stonepine Capital Management, LLC · 6 quarters on record
This page tracks every 13F SEC filing in which Stonepine Capital Management, LLC reported a position in KIORA PHARMACEUTICALS INC (KPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 131,144 | -9,454 | -6.7% | 0.19% | $258K | $1.97 |
| 2025 Q3 | REDUCED | 140,598 | -37,402 | -21.0% | 0.32% | $390.9M | $2.78 |
| 2025 Q2 | REDUCED | 178,000 | -22,647 | -11.3% | 0.50% | $513K | $2.88 |
| 2025 Q1 | REDUCED | 200,647 | -323 | -0.2% | 0.59% | $603.9M | $3.01 |
| 2024 Q4 | REDUCED | 200,970 | -1,430 | -0.7% | 0.54% | $663K | $3.30 |
| 2024 Q3 | INITIATED | 202,400 | — | — | 0.47% | $741K | $3.66 |
As of 2025 Q4 — sorted by position size